Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.47% | -30.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.03% | -22.22% | |||
| Operating Income | 158.75% | 20.11% | |||
| Income Before Tax | 180.32% | 27.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 180.32% | 27.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 180.32% | 27.69% | |||
| EBIT | 158.75% | 20.11% | |||
| EBITDA | 159.54% | 20.16% | |||
| EPS Basic | 180.31% | 27.74% | |||
| Normalized Basic EPS | 180.33% | 27.73% | |||
| EPS Diluted | 171.02% | 23.25% | |||
| Normalized Diluted EPS | 175.59% | 27.73% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | 6.26% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||